【レポートの概要(一部)】
1. Report Overview
1.1 Global Pain Management Devices Market Overview
1.2 Global Pain Management Devices Market Segmentation
1.3 Why You Should Read This Report
1.4 How This Report Delivers
1.5 Key Questions Answered by This Analytical Report
1.6 Who is This Report For?
1.7 Methodology
1.8 Frequently Asked Questions (FAQ)
1.9 Associated Reports
1.10 About Visiongain
2. An Introduction to Pain and Pain Management
2.1 Pain: A Sensory And Emotional Phenomenon
2.1.1 Pain: A Short History
2.1.2 Pain Pathways And The Origin Of Pain
2.2 The World Health Organisation (WHO) Pain Ladder
2.2.1 Classification Of Pain
2.2.1.1 Acute Pain
2.2.1.2 Chronic Pain
2.3 The Psychosocial Effects Of Chronic Pain
2.3.1 Chronic Cancer Pain
2.3.2 Neuropathic Pain
2.3.3 Identifying Neuropathic Pain
2.4 The Neurochemistry Of Pain
2.4.1 Prostaglandins
2.4.2 Opioids
2.5 Pain Management – A Brief Overview
2.6 Pain Management Drugs
2.6.1 The Use Of Opioids In Pain Management
2.6.2 OTC Pain Relievers
2.7 Pain Management Devices
2.7.1 Radiofrequency Ablation Devices
2.7.2 Analgesic Pumps
2.7.2.1 Types Of Infusion
2.7.2.2 Advantages And Disadvantages Of Infusion Pumps
2.7.3 Intradiscal Electrothermal Therapy
2.7.4 Neurostimulation
2.7.4.1 Spinal Cord Stimulation
2.7.4.2 Deep Brain Stimulation
2.7.4.3 Occipital Nerve Stimulation
2.7.5 Microcurrent Electrical Neuromuscular Stimulation
2.7.6 Transcutaneous Electrical Nerve Stimulation
2.8 Medical Devices Classification Systems
2.8.1 The US Medical Devices Classification System
2.8.2 The EU Medical Devices Classification System
2.9 Regulation Of Medical Devices
2.9.1 The US Approval And Regulation System
2.9.2 The EU Approval And Regulation System
2.9.2.1 Post-Marketing Surveillance In The EU
2.10 Market Definition
3. The Global Pain Management Devices Market: By Device Type, 2014-2024
3.1 The Global Pain Management Market In 2013
3.2 Pain Management Devices: Global Market Overview
3.2.1 The Global Pain Management Devices Market In 2013
3.2.2 Global Pain Management Devices: Market Forecast 2014-2024
3.2.3 Changing Market Shares By Sector 2014-2024
3.3 Analgesia Infusion Pumps Market 2014-2024
3.3.1 Intrathecal Drug Delivery Systems
3.3.2 Patient Controlled Analgesia
3.3.2.1 Costs And Benefits Of PCA Pumps
3.3.2.2 PCA Pumps: Leading Products, 2014
3.3.3 Analgesia Infusion Pumps: Market Forecast 2014-2024
3.4 Spinal Cord Stimulation Market 2014-2024
3.4.1 Spinal Cord Stimulation: Leading Products, 2014
3.4.2 Spinal Cord Stimulation For Pain Management: Market Forecast 2014-2024
3.5 Radiofrequency Ablation Market 2014-2024
3.5.1 Radiofrequency Ablation for Pain Management: Leading Products, 2014
3.5.2 Radiofrequency Ablation for Pain Management: Market Forecast 2014-2024
3.6 Intradiscal Electrothermal Therapy 2014-2024
3.6.1 Intradiscal Electrothermal Therapy for Pain Management: Market Forecast 2014-2024
3.7 Transcutaneous Electrical Nerve Stimulation 2014-2024
3.7.1 Transcutaneous Electrical Nerve Stimulation: Leading Products, 2014
3.7.2 Transcutaneous Electrical Nerve Stimulation For Pain Management: Market Forecast 2014-2024
3.8 Microcurrent Electrical Neuromuscular Stimulation 2014-2024
3.8.1 Microcurrent Electrical Neuromuscular Stimulation For Pain Management: Market Forecast 2014-2024
3.9 Other Pain Management Devices 2014-2024
3.9.1 Occipital Nerve Stimulation As A Pain Management Therapy
3.9.2 Deep Brain Stimulation As A Pain Management Therapy
3.9.3 Other Pain Management Devices: Market Forecast 2014-2024
4. The Global Pain Management Devices Market: By Application, 2014-2024
4.1 Chronic Pain: Variable Causes And Related Conditions
4.2 Pain Management Devices: Applications and Uses
4.2.1 Pain Management Devices Market By Application In 2013
4.2.2 Global Pain Management Devices By Application: Market Forecast 2014-2024
4.2.3 Changing Market Shares By Application 2014-2024
4.3 Musculoskeletal Pain Management Devices Market 2014-2024
4.3.1 Musculoskeletal Pain Management Devices: Leading Products, 2014
4.3.2 Musculoskeletal Pain Management Devices: Market Forecast 2014-2024
4.4 Cancer Pain Management Devices Market 2014-2024
4.4.1 Cancer Pain Management Devices: Leading Products, 2014
4.4.2 Cancer Pain Management Devices: Market Forecast 2014-2024
4.5 Migraine and Facial Pain Management Devices Market 2014-2024
4.5.1 Migraine Relieving Techniques
4.5.2 Migraine Pain Management Devices: Leading Products, 2014
4.5.3 Migraine And Facial Pain Management Devices: Market Forecast 2014-2024
4.6 Neuropathic Pain Management Devices Market 2014-2024
4.6.1 Neuropathic Pain Management Devices: Leading Products, 2014
4.6.2 Neuropathic Pain Management Devices: Market Forecast 2014-2024
4.7 Surgical And Trauma Pain Management Devices Market 2014-2024
4.7.1 Surgical And Trauma Pain Management Devices: Leading Products, 2014
4.7.2 Surgical And Trauma Pain Management Devices: Market Forecast 2014-2024
4.8 The Market For Other Pain Management Devices 2014-2024
4.8.1 The Market For Other Pain Management Devices: Market Forecast 2014-2024
5. Leading National Pain Management Devices Markets 2014-2024
5.1 The Pain Management Devices Market By Region
5.1.1 The Global Distribution Of Pain Management Devices In 2013
5.2 Leading National Markets: Forecast, 2014-2024
5.2.1 Changing Market Shares By Region, 2014-2024
5.3 Regional Pain Management Devices Markets: Analysis and Forecasts, 2014-2024
5.4 United States: The Largest Pain Management Devices Market
5.5 The EU5 Markets
5.5.1 EU5 Markets: Changing Market Shares by Country, 2014-2024
5.5.2 Germany: Fiscal Austerity Programs And Spending Cuts Impacting Market Growth
5.5.3 France: Price Reductions And Lowering Consumption Are Concerns For Market Growth
5.5.4 UK: Private Patient Income Will Help To Offset Low Funding Levels
5.5.5 Italy: Restrictions On The Use Of Analgesic Drugs To Help Boost Pain Devices
5.5.6 Spain: Rationalisation Of Health And Pharmaceutical Expenditure Limiting Market Growth
5.6 China: Shifting Technological Landscape Will Drive Market Growth
5.7 Japan: An Ageing Population Coupled With The Fear Of Opioid Addiction Will Stimulate Pain Devices Uptake
5.8 India: Rising Pain Incidence And Improving Socio-Economic Conditions
5.9 South Korea: Universal Healthcare Coverage And Government Investment Fuelling Market Growth
5.10 Russia: Improving Market Penetration For Pain Devices
5.11 Brazil: Inadequate Infrastructure Limiting Expansion
5.12 Mexico: Heavy Regulation Of Opioid Use To Strengthen Device Uptake
5.13 Rest Of The World
6. Leading Companies in the Pain Management Devices Market, 2014
6.1 Pain Management Devices – A Diversified Market
6.2 BioDelivery Sciences International (BDSI)
6.2.1 BDSI – The BEMA Technology Platform
6.2.2 BDSI: Historical Revenue Analysis, 2009-2013
6.3 Boston Scientific
6.3.1 Boston Scientific: Revenue Analysis, 2013
6.3.2 Boston Scientific – Precision And Precision Spectra Spinal Cord Stimulation Systems
6.3.3 GUIDE DBS And Enspire DBS Systems – Intelect Medical/Boston Scientific
6.4 Cephalon (Teva Pharmaceuticals)
6.4.1 Cephalon’s Pain Management Products
6.4.1.1 Actiq – Cephalon’s Therapy For Cancer Pain
6.5 DJO Global (Empi Inc)
6.5.1 Empi Inc
6.5.2 Empi’s Electrotherapy Products
6.5.3 Empi’s Iontophoresis Patch Systems
6.6 Endo Pharmaceuticals
6.6.1 Endo Pharmaceuticals: Historical Revenue Analysis, 2011-2013
6.6.2 Endo Pharmaceuticals Pain Management – Lidoderm
6.7 Hospira
6.7.1 Hospira: Historical Revenue Analysis, 2009-2013
6.7.2 Hospira – LifeCare PCA Infusion System
6.8 Kimberly-Clark Health Care
6.8.1 Kimberly-Clark: Revenue Analysis
6.8.2 Kimberly-Clark’s Cooled Radiofrequency System for Chronic Pain Relief
6.9 Medtronic
6.9.1 Medtronic: Historical Revenue Analysis, 2013-2014
6.9.2 Medtronic Pain Management Products
6.9.2.1 RestoreSensor Neurostimulator
6.9.2.2 RestoreUltra Neurostimulator
6.9.2.3 SynchroMed II Drug Pump
6.10 Pain Management Technologies Inc
6.10.1 Pain Management Technologies Inc’s Products
6.11 St Jude Medical
6.11.1 St Jude Medical: Historical Revenue Analysis, 2009-2013
6.11.2 St Jude Medical: Pain Management Products
6.11.3 Axium Neurostimulator System – SJM and Spinal Modulation
7. Pain Management Devices: R&D Pipeline 2014-2024
7.1 Peripheral Nerve Stimulation – Pipeline Products
7.1.1 Altius System High Frequency Nerve Block (Neuros Medical)
7.1.2 MicroStim System (MicroTransponder Inc)
7.1.3 Senza SCS System (Nevro Corporation)
7.2 Analgesic Infusion Systems – Pipeline Products
7.2.1 Programmable Implantable DDS (Palyon Medical Corporation)
7.2.2 Zalviso (AcelRx Pharmaceuticals)
7.3 Occipital Nerve Stimulation – Pipeline Products
7.3.1 Precision System (Boston Scientific)
7.4 Radiofrequency Ablation – Pipeline Products
7.4.1 Intracept (Relievant Medsystems Inc)
8. Qualitative Analysis of the Pain Management Devices Market, 2014-2024
8.1 SWOT Analysis Of The Pain Management Devices Market, 2014-2024
8.1.1 Strengths
8.1.1.1 Cost Effectiveness: A Central Driver For Growth
8.1.1.2 Positive Side Effect Profile Of Pain Management Devices Compared With Pain Relieving Drugs
8.1.2 Weaknesses
8.1.2.1 Short Term Pain Relief
8.1.2.2 Mechanisms Of Action Not Fully Understood
8.1.2.3 Lack Of Evidence To Support The Efficacy And Safety Of Some Therapies
8.1.2.4 Devices Failing In Clinical Trials
8.1.2.5 Education In Pain Management Is A Key Unmet Need
8.1.3 Opportunities
8.1.3.1 Expanding Disease Indications Driving Neurostimulation for Pain Relief
8.1.3.2 The Potential Of Personalised Medicine
8.1.3.3 Expansion Into Emerging Markets
8.1.3.4 Ageing Population – Growth Driver For Pain Management
8.1.4 Threats
8.1.4.1 Increasing Regulatory And Pricing Scrutiny
8.1.4.2 Medical Device Excise Tax: A Drain On Innovation?
8.1.4.3 Inadequate Reimbursement Levels Limits Potential Of Pain Devices
8.2 Porter’s Five Force Analysis Of The Pain Management Device Market
8.2.1 Threat Of Substitutes: High
8.2.2 Power Of Suppliers: Medium
8.2.3 Rivalry Among Competitors: Medium
8.2.4 Bargaining Power Of Buyers: High
8.2.5 Threat Of New Entrants: Medium
9. Expert Opinions
9.1 Interview With Dr Deepak Kotak, Executive Vice President, BioElectronics Corporation
9.1.1 Pain Management Devices: Market Stratification And Brief History
9.1.2 On The Direct And Related Costs Of Pain And Pain Management
9.1.3 BioElectronics’ Products – FDA Approvals And The Quest For OTC Status
9.1.4 BioElectronic’s Product Distribution Partnerships And Entry Into The Advanced Wound Care Markets
9.1.5 On The Future Plans For Product Launch
9.1.6 The Issue Of Efficacy And Healthcare Economics And Their Impact On Pain Management Devices
9.1.7 On Future Technological Developments – Vagal Nerve And Trigeminal Nerve Stimulation
9.1.8 On The Future Challenges And Opportunities Facing Pain Management Devices Over The Next Decade
9.2 Interview With Penney Cowan, Chief Executive Officer, American Chronic Pain Association
9.2.1 On The Current State Of The Pain Management Devices Market
9.2.2 Socio-Political Influences On Pain Management Device And The Current Trends In The Market
9.2.3 ACPA’s Role In Patient Empowerment And Pain Management
9.2.4 ACPA’s Corporate Strategy And Future Plans
9.2.5 On The Misconceptions Surrounding Pain And Pain Management
9.2.6 On Factors That Will Affect Future Technology Developments In Pain Management
9.2.7 Interdisciplinary Pain Management As An Opportunity For Market Growth
10. Conclusion
10.1 Market Overview
10.2 Commercial Drivers For Pain Management Devices
10.3 Neuromodulation Looks Set For High Growth
10.4 Rising Demand From Musculoskeletal Pain Will Drive Market Growth
10.5 Leading Developers Of Pain Management Devices
10.6 Growth Concentrated In The Developed Markets Of North America And Europe
10.7 Future Prospects For Pain Management Devices
【レポート販売概要】
■ タイトル:世界の疼痛管理用デバイス市場予測:鎮痛剤注入ポンプ/脊髄刺激/高周波アブレーション等■ 英文:Pain Management Devices Market Forecast 2014-202
Future Prospects for Leading Companies
■ 発行日:2014年6月
■ 調査会社:visiongain
■ 商品コード:VISG409049
■ 調査対象地域:グローバル
- 炭酸フルオロエチレンの世界市場2015FLUOROETHYLENE CARBONATE (FEC) (CAS 114435-02-8) Market Research Report 2015 aims at providing comprehensive data on FLUOROETHYLENE CARBONATE (FEC) market globally and regionally (Europe, Asia, North America, Latin America etc.) The report includes FLUOROETHYLENE CARBONATE (FEC) description, covers its application areas, manufacturing methods, patterns. It captures FLUOROETHYLENE CARBONATE (FEC) m …
- 整形外科手術ロボットの世界市場2017-2021ABSTRACTAbout Orthopedic Surgical Robots Orthopedic surgical robots are systems that are used to perform surgeries such as partial or joint replacement, which is also known as arthroplasty. The current report focuses on robots that are used to conduct orthopedic surgeries on the hip and knee. With the developments in the orthopedic market, there has been an emergence of product offerings, which fa …
- ニューロモーフィック・チップの世界市場予測及び分析Neuromorphic chips are brain inspired electronic chips made out of multiple neurons. Combination of several artificial neural network chips is called Neuromorphic architecture. Current microprocessors can crunch numbers seamlessly, but they are terrible at tasks that brains do with ease. Motivation behind designing these chips is to build a platform for running large-scale, real-time simulations t …
- 構造的心臓デバイスの世界市場分析:タイプ別(外科的大動脈弁置換術[SAVR]、経カテーテル大動脈弁置換術[TAVR]、僧帽弁修復(弁形成術)、左心房付属弁閉鎖[LAAC])、地域別、セグメント予測、2014 – 2025The global structural heart devices market is expected to reach USD 9.1 billion by 2025, based on a new report by Grand View Research, Inc. The market is expected to witness an exponential growth over the next 8 years due to the rapid increase in cardiovascular conditions and increasing power of healthcare expenditure. The defects are mostly present at birth, thereby directly affecting the under-5 …
- 複合材料の世界市場:炭素繊維複合材、ガラス繊維複合材、アラミド繊維複合材、天然繊維複合材The composites market size of end products in terms of value is projected to reach around $90 billion by 2020 and expected to grow at a CAGR of 7% to 9% between 2015 and 2020. Asia-Pacific held the largest share by volume in composites market in 2014. Major growth in the Asia-Pacific region is expected from the growing construction, aerospace and electronics & semiconductor application. The compos …
- ウィルソン病治療薬の世界市場2019-2023129 pages, October 2018 About this market The increase in strategic alliances to help market grow. Pharmaceutical companies are engaging in strategic alliances for the development of medications for the treatment of Wilson’s disease. These alliances enhance the R&D activities for new drugs for the treatment of Wilson’s disease. Technavio’s analysts have predicted that the Wilson’s disease drugs ma …
- たばこ製造・販売企業分析:Organisation Generale de TabacsSynopsis This report provides a unique and comprehensive analysis of the company Global, Regional and National Tobacco Players: Organisation Generale de Tabacs, including the corporate profile, organisation structure, financial data, and competitive positioning. The analysis also details the organisation's history, merger and acquisition activity, licensing agreements, brand portfolio, as well as …
- 自閉症(Autism):グローバル臨床試験レビュー(2014年上半期)Autism Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Autism Global Clinical Trials Review, H1, 2014" provides data on the Autism clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Autism. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction ac …
- Tasigna (Chronic Myeloid Leukemia):市場予測と分析(~2022)Tasigna (Chronic Myeloid Leukemia) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “Tasigna (Chronic Myeloid Leukemia) - Forecast and Market Analysis to 2022”. Chronic myeloid leukemia (CML) is a rare myeloproliferative blood cancer that is characterized by the presence of the BCR-ABL fusion protein. The stage of CML is classified …
- ヒト・マイクロバイオームの世界市場:プロバイオティクス、食品、プレバイオティクス、医療食品、診断デバイス、医薬品、サプリメントThe human microbiome market is segmented by application, disease, product, and geography while the human microbiome research spending market is broadly segmented by product and technology. The human microbiome market is expected to reach USD 658 Million by 2023 from USD 294 Million in 2019 growing at a CAGR of 22.3% during the forecast period (2019–2023). The market is driven by growing incidences …
- RFID Deployment and Analysis with Business Plan and Company AnalysisRadio Frequency Identification (RFID) is proving to be one of the best solutions for tracking and identifying assets globally. It can be used for many functions including locating items, provide quick identification and tracking of medicines in the hospitals, tracking animals, etc. RFID can be deployed in various market verticals for tracking and managing moveable assets. It is arguably the most p …
- アルミニウム鋳造の世界市場:アルミニウムダイカスト、アルミニウム金型鋳造About Aluminum Casting Casting is used for making geometrically complex parts using metals and cold setting materials. It is of two types: ferrous and non-ferrous. Aluminum, zinc, magnesium, and copper-based alloys are the most common non-ferrous metals used for casting. Aluminum cast components are used in the manufacturing of sub-assemblies of planes, vehicles, and trains. They are also used in …
- 自動車V2X(車車間/路車間通信)の世界市場予測(~2022):V2V、V2I、V2P、V2G、V2H、V2NAccording to the MarketsandMarkets forecast, the automotive V2X market is expected to be valued at USD 767.5 Million in 2017 and is expected to reach USD 2,815.5 Million by 2022, at a CAGR of 29.69% between 2017 and 2022. . Demand for real-time traffic and incident alerts for increasing public safety, increasing financial aid from various government funds for better traffic management, and increas …
- Heart Transplantation:グローバル臨床試験レビューH2, 2013Heart Transplantation Global Clinical Trials Review, H2, 2013 Summary GlobalData's clinical trial report, “Heart Transplantation Global Clinical Trials Review, H2, 2013" provides data on the Heart Transplantation clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Heart Transplantation. It includes an overview of the trial numbers and the …
- ファクトリーオートメーション(FA)PaaSの世界市場予測(~2022):ソリューション別、プラットフォーム別(資産管理、データ処理&分析)、プロフェッショナルサービス別、需要先産業別、地域別The top 10 cellular analysis market is expected to reach USD 41.34 Billion by 2021 from USD 28.66 Billion in 2016, at a CAGR of 7.6% during the forecast period. Cellular analysis is used for cell identification, cell interaction, cell viability, cell proliferation, cell structure study, cell signaling/cell transduction, target identification & validation, cell counting, and quality control. Curren …